Besides steatosis, GLP-1/GIP RAs ameliorated MASH by reinforcing hepatic insulin sensitivity, enhancing triglyceride lipolysis, and restricting the supply of free fatty acids in the liver [103]. The gene discussed is GLP1R; the disease is steatosis.